News
GMED
50.41
-2.00%
-1.03
GMED vs. PEN: Which Stock Is the Better Value Option?
NASDAQ · 1d ago
Weekly Report: what happened at GMED last week (0415-0419)?
Weekly Report · 3d ago
Globus Medical Schedules First Quarter Earnings Release and Conference Call
Globus Medical, Inc. Will announce its financial results for the first quarter ended March 31, 2024 after the market close on May 7, 2024. The company is a leading musculoskeletal solutions company. A copy of the release will be available on the Globus Medical website.
Barchart · 04/16 15:30
Weekly Report: what happened at GMED last week (0408-0412)?
Weekly Report · 04/15 09:04
BUZZ-Jefferies initiates India's 360 One Wam, Nuvama with buy; stocks rise
Jefferies initiates coverage on Indian wealth management co stocks 360 One Wam ONEW.NS and Nuvama Wealth Management NUVA.NS with buy. ONEW shares up as much as 3.9% to record high of 748.40 rupees. Indian wealth managers well-placed to ride on country's economic growth, brokerage says.
Reuters · 04/09 04:33
Globus Medical Breaks Above 200-Day Moving Average - Bullish for GMED
NASDAQ · 04/08 21:12
An Intrinsic Calculation For Globus Medical, Inc. (NYSE:GMED) Suggests It's 42% Undervalued
Glennus Medical, Inc. Is estimated to be 42% undervalued based on a discounted cash flow model. We use the 2-stage growth model to estimate the intrinsic value of the company. The company is projected to be worth US$89.01 based on 2 Stage Free Cash Flow to Equity. Our fair value estimate is 37% higher than Globus Medical's current share price of US$51.83.
Simply Wall St · 04/08 11:21
Weekly Report: what happened at GMED last week (0401-0405)?
Weekly Report · 04/08 09:04
Weekly Report: what happened at GMED last week (0325-0329)?
Weekly Report · 04/01 09:04
Don't expect pandemic backlog to fuel orthopedic sales, says Needham
Don't expect pandemic backlog to fuel orthopedic sales, says Needham & Co. The hip market grew the most last year, according to the investment bank. Needham says the backlog appears to have been largely exhausted, with 2023 sales modestly higher than they would have been without the pandemic.
Seeking Alpha · 03/31 23:46
Weekly Report: what happened at GMED last week (0318-0322)?
Weekly Report · 03/25 09:04
Globus Medical (GMED) Down 5.8% Since Last Earnings Report: Can It Rebound?
NASDAQ · 03/21 15:30
Globus Medical (NYSE:GMED) Seems To Use Debt Rather Sparingly
Globus Medical, Inc. Had US$417.4m of debt at the end of December 2023. The company has US$7.04b in debt, but has net cash to offset that. Globus Medical uses debt to fund its business, but does not have a heavy debt load. The balance sheet is a good indicator of a company's ability to manage its debt. The firm has a strong free cash flow of US$165m and grew its EBIT by 16% last year.
Simply Wall St · 03/20 12:52
1 'Strong Buy' Growth Stock Wall Street Expects to Soar Around 70%
Alphatec Holdings (ATEC) is a medical technology company focused on innovative spinal surgery solutions. The company's stock has returned 410% in the last five years. Alphatec is expected to grow its revenue by 68.5% in next 12 months. The stock is trading at 19 times its projected 2024 sales.
Barchart · 03/19 08:21
The Latest Analyst Ratings For Globus Medical
Globus Medical has an average price target of $63.83. The company is a medical device company that develops and provides healthcare products and solutions. The 12-month price targets for Globus Medical offer insights into the company's future prospects. 6.6 analysts have expressed a variety of opinions on Globus medical over the past quarter.
Benzinga · 03/18 15:01
Globus Medical Price Target Announced at $60.00/Share by BTIG
Dow Jones · 03/18 12:16
Globus Medical Raised to Buy From Neutral by BTIG
Dow Jones · 03/18 12:16
BTIG Upgrades Globus Medical to Buy, Announces $60 Price Target
Benzinga · 03/18 12:06
Strength in Technology Stocks Leads the Broader Market Higher
S&P 500 Index up +1.05% this morning, led by strength in technology stocks. Alphabet is up more than +6% on news Apple is in talks to build Google's AI engine into the iPhone. Tesla is up +5% on reports the company will raise the price of its Model Y cars in April. Bearish factor for stocks is today's rise in the 10-year T-note yield to a 3-week high. Market attention this week will focus on the Fed's FOMC meeting.
Barchart · 03/18 10:21
Stocks Rally on Strength in Technology Stocks
S&P 500 Index is moderately higher this morning, led by strength in technology stocks. Alphabet is up more than +6% after reports Apple is in talks to build Google's AI engine into the iPhone. Tesla is up +2% on news the company will raise the price of its Model Y cars in April. Interest rates this week will focus on the FOMC meeting. Overseas stock markets today are higher. June 10-year T-notes fell to a 3-week low today. European government bond yields are mixed.
Barchart · 03/18 09:16
More
Webull provides a variety of real-time GMED stock news. You can receive the latest news about Globus Med Inc through multiple platforms. This information may help you make smarter investment decisions.
About GMED
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the majority of conditions affecting the spine, including degenerative conditions, deformity, tumors, and trauma. It provides solutions that facilitate both open and minimally invasive surgery (MIS) techniques. It includes traditional fusion implants, such as pedicle screws and rod systems. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.